NOD2 and sarcoidosis: The first was whether the frequency of pulmonary lesions differed depending on the type of NOD2 mutations, the second was whether there was a trigger for enhancing NOD2 pathway activation, and the third was whether there were triggers for pulmonary lesion formation observed in adult sarcoidosis.